このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Middle East Healthcare 過去の業績
過去 基準チェック /56
Middle East Healthcareは、平均年間10.8%の収益成長を遂げていますが、 Healthcare業界の収益は、年間 成長しています。収益は、平均年間15.4% 13.6%収益成長率で 成長しています。 Middle East Healthcareの自己資本利益率は11.4%であり、純利益率は6.7%です。
主要情報
10.8%
収益成長率
10.8%
EPS成長率
Healthcare 業界の成長 | 12.3% |
収益成長率 | 13.6% |
株主資本利益率 | 11.4% |
ネット・マージン | 6.7% |
前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital
May 30Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 09If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity
Apr 29Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge
Apr 02There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump
Feb 11Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled
Feb 08Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?
Jan 18Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors
Dec 28Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends
Sep 26Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital
Jun 28Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital
Mar 30Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal
Sep 20Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)
Jun 14Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture
Apr 18Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital
Aug 10Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends
Mar 29An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued
Mar 03Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 10Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock
Jan 23If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%
Jan 05Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?
Dec 18Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)
Nov 30収支内訳
収支内訳
Middle East Healthcare の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
31 Mar 24 | 2,704 | 182 | 654 | 0 |
31 Dec 23 | 2,653 | 180 | 661 | 0 |
30 Sep 23 | 2,551 | 177 | 603 | 0 |
30 Jun 23 | 2,393 | 135 | 574 | 0 |
31 Mar 23 | 2,276 | 105 | 551 | 0 |
31 Dec 22 | 2,152 | 75 | 532 | 0 |
30 Sep 22 | 2,033 | 24 | 547 | 0 |
30 Jun 22 | 2,019 | 27 | 569 | 0 |
31 Mar 22 | 1,968 | 26 | 565 | 0 |
31 Dec 21 | 1,873 | 17 | 541 | 0 |
30 Sep 21 | 1,823 | 45 | 493 | 0 |
30 Jun 21 | 1,816 | 66 | 474 | 0 |
31 Mar 21 | 1,733 | 73 | 438 | 0 |
31 Dec 20 | 1,751 | 82 | 454 | 0 |
30 Sep 20 | 1,708 | 110 | 443 | 0 |
30 Jun 20 | 1,603 | 108 | 400 | 0 |
31 Mar 20 | 1,583 | 104 | 399 | 0 |
31 Dec 19 | 1,497 | 98 | 360 | 0 |
30 Sep 19 | 1,401 | 91 | 341 | 0 |
30 Jun 19 | 1,353 | 78 | 344 | 0 |
31 Mar 19 | 1,346 | 100 | 335 | 0 |
31 Dec 18 | 1,391 | 172 | 326 | 0 |
30 Sep 18 | 1,445 | 224 | 317 | 0 |
30 Jun 18 | 1,459 | 269 | 304 | 0 |
31 Mar 18 | 1,464 | 297 | 300 | 0 |
31 Dec 17 | 1,462 | 319 | 297 | 0 |
30 Sep 17 | 1,503 | 322 | 342 | 0 |
30 Jun 17 | 1,529 | 356 | 372 | 0 |
31 Mar 17 | 1,588 | 368 | 426 | 0 |
31 Dec 16 | 1,616 | 363 | 466 | 0 |
30 Sep 16 | 1,629 | 380 | 462 | 0 |
30 Jun 16 | 1,602 | 371 | 448 | 0 |
31 Mar 16 | 1,564 | 389 | 425 | 0 |
31 Dec 15 | 1,535 | 390 | 418 | 0 |
30 Sep 15 | 1,485 | 373 | 413 | 0 |
30 Jun 15 | 1,456 | 356 | 424 | 0 |
31 Mar 15 | 1,431 | 357 | 405 | 0 |
31 Dec 14 | 1,399 | 332 | 424 | 0 |
31 Dec 13 | 828 | 137 | 285 | 0 |
質の高い収益: 4009は 高品質の収益 を持っています。
利益率の向上: 4009の現在の純利益率 (6.7%)は、昨年(4.6%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 4009の収益は過去 5 年間で年間10.8%増加しました。
成長の加速: 4009の過去 1 年間の収益成長率 ( 73.6% ) は、5 年間の平均 ( 年間10.8%を上回っています。
収益対業界: 4009の過去 1 年間の収益成長率 ( 73.6% ) はHealthcare業界19.9%を上回りました。
株主資本利益率
高いROE: 4009の 自己資本利益率 ( 11.4% ) は 低い とみなされます。